From cancer to infectious diseases to neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, there ...

Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among ...

SandboxAQ, an artificial intelligence startup spun out of Alphabet's Google and backed by Nvidia, on Wednesday released a ...

Regulatory science also plays a crucial role in ensuring public trust in these products and facilitating the translation of ...

UB scientists Ram Samudrala and Zackary M. Falls talk about the new platform to make drug discovery faster and less expensive ...

Symbiotic.blue, a biotech looking to build an AI-driven drug discovery platform, has begun a pre-seed funding round.

In a time of relentless AI hype and mounting global economic uncertainty, the real winners will be those who think long-term.

ZS’s India hub is reshaping global healthcare by pioneering AI and GenAI applications in drug discovery, clinical trials, and ...

SandboxAQ, an AI startup, has launched a huge dataset. It will speed up the finding of new medical treatments. The dataset ...

Over the past year, drug discovery has gotten a massive boost from the CAS BioFinder Discovery Platform, which allows scientists to explore known and predicted data that accelerate the preclinical ...